The Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE) is an international research consortium funded by the Bill & Melinda Gates Foundation to assess the impact of novel strategies for controlling HIV-related TB. It has funded three large cluster-randomised trials including the ZAMSTAR and Thibela TB studies, in which TB Centre researchers have leading roles.